Divalproex Sodium Extended-Release 1000 mg Tablet

Divalproex Sodium Extended-Release 1000 mg Tablet is a extended-release tablet formulated with 1000 mg. The active ingredient profile is Divalproex Sodium, placing the product in the anticonvulsant / mood-stabilizing agent category. Divalproex Sodium is an anticonvulsant and mood-stabilizing medicine with indication and monitoring requirements that depend on the approved product label. The modified-release designation indicates a controlled release presentation and must be described and administered exactly as stated in the approved product literature. For website cataloguing, composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. The description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and the prescriber’s judgement. Prescription status, precautions, interactions, adverse effects and dosing must be checked against the current approved product label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.